The ABO blood group is determined by the presence of A and B antigens on the surface of the red blood cells, and of anti -A or anti -B antibodies in the serum. Thus, the red blood cells of blood type A possess antigen A and the serum containing anti -B antibody. Similarly, blood type B has antigen B and anti -A antibody. Blood type AB contains both A and B antigens but no antibodies. Blood type O has no antigens but contains both anti -A and anti -B antibodies. Anti -A and anti -B antibodies are usually IgM type, and not present in newborns, but This article reviews the serology, biochemistry and genetic characteristics, and clinical application of ABO antigens.
INTRODUCTION
The ABO blood group system was discovered by Austrian scientist, Karl Landsteiner, who found three different blood types (A, B and O) in 1900 from serological differences in blood called the Landsteiner Law (1) . In 1902, DesCasterllo and Sturli discovered the fourth type, AB (2) . The ABO blood group is most important among the 29 blood group systems (Table 1) , and consists of four antigens (A, B, O and AB) (3, 4) . In 1924, Felix Bernstein predicted by extensive family studies that the mechanism of inheritance involved in three alleles at the ABO locus (5) . Furthermore, the structure and biochemical characteristics of the ABO antigens were elucidated by many investigators.
The genes of ABO blood group has been determined at chromosome locus 9 (6-9), and Yamamoto, et al. cloned and determined the structures. It has made it possible to analyze genetically ABO blood group antigens using molecular biology techniques (7, 10 -18) . appear in the first year of life. It is possible that the antibodies are produced against food and environmental antigens (bacterial, viral or plant antigens) (19, 20) , which are similar in structure to A and B antigens. This is summarized in Table 2 (21).
BIOCHEMISTRY

1) ABO blood group
A) Model of antigen carrier proteins
Blood group antigens are surface markers on the red cell, and consist of proteins and carbohydrates attached to lipids or proteins. A model of the membrane components carrying blood group antigens is shown in Figure 1 (22) .
B) The structure and biosynthesis of ABO antigens ABO antigens are one of the oligosaccharides antigens (23) . These antigens are widely expressed on the membranes of red cell and tissue cell as well as, in the saliva and body fluid (24) .
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!: Blood group collections or high indence antigen. The Ch/Rg and Sciamma blood group system are not shown in this figure. GlcNAcβ-R, Galα1!(Fucα1!2)3Galβ1!4GlcNAcβ-R, and (Fucα1!2)Galβ1!4GlcNAcβ -R, respectively, which are synthesized from the H antigen structure by the action of specific glycosyltransferase products of ABO genes. The A and B alleles encode glycosyltransferase (α1,3 -N -acetylgalactosaminyltransferase (A transferase) and α1,3 -galactosyltransferase (B transferase)), which catalyze the addition of specific sugars, N -acetylgalactosamine (GalNAc) and galactose (Gal) residue, respectively, in a α1!3 linkage on terminal Gal of H antigen (6, 26 -28) . Since O allele encodes proteins without glycosyltransferase (O transferase) function, H antigen is the only ABO structure present in blood type O (29).
C) Structure of the ABO gene locus Human ABO genes are located in chromosome 9q34.1 -q34.2(6 -9) and consists of 7 exons distributed over 18 kb of genomic DNA. Exon 7 contains most of the largest coding sequence. Exon 6 contains the deletion found in most O alleles. The exons range in size from 28 to 691 bp (29) .
The ABO locus has three main allele forms, A, B, and O. A and B alleles have seven nucleotide substitutions (297A!G, 526C!G, 657C!T, 703G! A, 796C!A, 803G!C and 930G!A). Four nucleotide substitutions (526C!G, 703G!A, 796C!A and 803G!C) are translated into different amino acid substitutions (Arg526Gly, Gly703Ser, Leu796Met and Gly803Ala). These substitutions determine the specificities of glycosyltransferases. The A allele encodes A transferase catalyzing the addition of GalNAc residue, and the B allele encodes B transferase catalyzing the addition of Gal residue, respectively, in a α1!3 linkage on terminal Gal of the H antigen. On the other hand, the O allele differs from the A allele by a single nucleotide deletion of guanine (G) at position 261. This deletion causes a frame -shift and results in a loss of transferases activity (Figure 3 ) (29 -31) . Blood type A appears to have the most variation in subgroups. Blood type A with a normal quantity of antigen is called A1, and is distinguished from subgroups. Subgroups are classified by the quantity of A antigen, and the amount of A antigen decreases in the order A1, A2, A3, Ax, Aend, Am, Ael. In Europeans, approximately 80% of blood type A and AB belong to A1, the remaining 20% are either A2 or A2B (in Japanese it is approximately 0.2%) (32, 33) .
In general, serologic distinction between A1 and A2 is based on the agglutination of A1 red blood cells but not A2 cells with anti -A1 lectin (extract of Dolichos biflorus seeds) (34). Recently, the sequence of A2 allele coding blood type A2 has been molecular genetically analyzed, and shown to have a single base deletion near the carboxyl terminal. The deletion causes a frame -shift and results in a loss of A2 transferase activity. This deletion of A2 allele made it possible to analyze genetically blood type A2 (35) . Similarly, subtypes of blood type B are classified by the quantity of B antigen, and the amount of B antigen decreases in the order B, B3, Bx, Bm, Bel. The expression of A or B antigens is summarized in Table 3 (36, 37).
B) Subgroups of AB
Blood type AB is classified into nine subtypes (AxB, A1Bx, AmB, A1Bm, AelB, A1Bel, cisA2B3, cisA2B, cisA1B3) by the quantity of A or B antigen. In particular, cisAB is a very rare phenotype and has three blood types, cisA2B3 (A2B3 /O ), cisA2B (A2B3 / B ), cisA1B3 (A2B3 /A1). Detecting this AB variant is very important, especially in blood transfusion and in dissolving a problem of paternity in the ABO blood group system. In 1964, Seyfried, et al. reported a family consisting of a woman with AB, her husband with blood type O, and daughter with blood type AB. They described the strange inheritance of blood type A and B and suggested that these specificities might be coded by genes located on the same chromosome (38) .
In 1966, Yamaguchi, et al. reported a family which consisted of three children with blood group A2B3 born to a father (blood type O) and mother (blood group A2B3). This family lived in Tokushima Prefecture in Japan. This finding showed that the A and B genes were located on the same chromosome. They proposed the name ''CisAB'' to distinguish it from ordinary AB, namely ''Trans AB'' (39) . It has been reported that the frequency of this phenotype is apparently higher in Tokushima, Ishikawa and Kagawa Prefectures than in other prefectures in Japan. For example, the frequency of the cisAB phenotype in Tokushima Prefecture (0.017% -0.02%) is about 11 times as high as that in Osaka Prefecture (0.0014% -0.0017%) (40, 41) . Furthermore, it is interesting that some cisAB families in other prefectures had actually moved from Tokushima over the last several generations. These findings suggest that families with the cisAB blood phenotype might have common ancestors.
Recently, the nucleotide sequence of the coding region in the last two coding exons of ABO genes from cisAB individuals was determined. CisAB (A2 B3) alleles were identical to one another while different from the A1 allele by two nucleotide substitutions (Figure 4) . Both of these nucleotide substitutions result in amino acid substitutions (42) . The first substitution is identical to that previously found in the A2 allele, corresponding to the cisAB (A2B3) allele encoding a glycosyltransferase that is capable of synthesizing both A and B antigens (17, 18, 35) .
Therefore, the phenotype of the ABO blood group system, such as subgroups of A, B and AB, have been realized by changes in the cDNA sequence, for example, base substitution or deletion.
Comparison of the nucleotide sequences of alleles in A, B and AB subgroups is summarized in the 
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GENETIC ANALYSES OF ABO BLOOD GROUPS AND THEIR APPLICATIONS FOR CLINICAL STUDIES
Gene technology using PCR has markedly advanced in recent years and has been introduced into clinical laboratories. Accordingly, genotypes of the ABO blood group have been analyzed using polymerase chain reaction -restriction fragment length polymorphism (PCR -RFLP), PCR -direct sequencing, PCR -single strand conformation polymorphism (PCR -SSCP), and PCR -amplification of specific alleles (PASA). PCR -RFLP, PCR -direct sequencing and PCR -SSCP methods require 2 -step procedures, and then not ease to be used in clinical laboratories. The PASA method is based on the fact that PCR amplification occurs only when the 3' endbase of the primer is matched to the nucleotide of No. 261, 526, 796 or 803 (the sites of amino acid substitutions) of ABO allelic cDNA, and three of five regions of allelic DNAs were co -amplified in single PCR (multiplex -PCR) in our study (8, 12 -16) . ABO and cisAB blood group genotypes were directly determined, based on the molecular size of allele -specific amplification products. The PASA method requires only about 4 hours from the start of PCR to the end of analysis. Therefore, PASA method is rapid, simple and useful for detecting the genotype of ABO and cisAB blood groups in comparison with PCR -RFLP, PCR -direct sequencing and PCR -SSCP methods and used widely throughout the research and clinical laboratories.
The scheme of the method of amplification and the analysis of specific ABO and cisAB alleles using the PASA method are shown in Figure 5 (14) .
1) ABO genotyping
As shown in Figure 6 , and cisAB (55bp) were amplified by PCR with 5 pairs of primers (primer 1 and 2, primer 3 and 4, primer 5 and 6, primer 7 and 8, and primer 9 and 10), respectively. Three (104bp, 224bp and 379bp) of five fragments were co-amplified in a single PCR -1 (multiplex -PCR).
2) cisAB genotyping
As shown in Figure 7 (13, 14) , all genes of the three major cisAB genotypes, A2B3/O , A2B3/A1 and A2B3/B were amplified ; four specific bands (379, 104, 52 and 55 bp) for A2B3/O , three specific bands (379, 52 and 55 bp) for A2B3/A1 and four specific bands (379, 224, 52 and 55 bp) for A2B3/B . Table 5 summarizes all possible specific band patterns of the ABO genotype obtained with the PASA method. ABO and cisAB blood group genotypes were directly determined, based on the molecular size of allele -specific amplification products. The analysis of nucleotide sequence in three major subjects in the cisAB blood group revealed chimeric structures of the A allele and B allele on the same gene. PCR products in the three major cisAB genotypes. Genomic DNA extracted from leukocytes was amplified by PASA method using 5 primer sets (primer 1 and 2, primer 3 and 4, primer 5 and 6, primer 7 and 8, and primer 9 and 10). M, Hae III digest of Plasmid pBR322 (marker) ; upper panel : ABO allele specific ; Lower panel : cisAB allele specific.
